Feature Channels: Dermatology

Filters close
Newswise: Is It True That Tattoos Can Increase Your Risk of Getting Skin Cancer?
Released: 16-Mar-2023 3:45 PM EDT
Is It True That Tattoos Can Increase Your Risk of Getting Skin Cancer?
Ochsner Health

With more people getting tattoos, this important blog addresses the possible health risks that may come along with this practice.

Released: 14-Mar-2023 9:00 AM EDT
Expert Dermatologists Present Latest Information at 2023 AAD Annual Meeting
American Academy of Dermatology

The 2023 American Academy of Dermatology Annual Meeting will take place March 17-21 at the Ernest N. Morial Convention Center in New Orleans.

7-Mar-2023 2:00 PM EST
Painful, swirling skin lesions a rare symptom of undiagnosed pulmonary tuberculosis
American College of Physicians (ACP)

A patient presenting with painful, swirling skin lesions, chills, and weight loss was found to be suffering from erythema gyratum repens (EGR), a rare and striking skin condition that is associated with underlying malignancy in most cases, but in some cases can stem from an autoimmune disease, messenger RNA-based vaccines against COVID-19, or in rare cases, tuberculosis (TB). The case report from authors at Stanford University is published in Annals of Internal Medicine.

Newswise: Bosenberg named Brady Professor of Dermatology, Pathology and Immunobiology
Released: 9-Mar-2023 4:30 PM EST
Bosenberg named Brady Professor of Dermatology, Pathology and Immunobiology
Yale Cancer Center/Smilow Cancer Hospital

Dr. Marcus Bosenberg, an accomplished clinician, teacher, and researcher who studies the factors that regulate anti-cancer immune responses, was recently appointed the Anthony N. Brady Professor of Dermatology, Pathology, and Immunobiology, effective immediately.Bosenberg received his Ph.D. and M.D. at Cornell University Medical College.

1-Mar-2023 3:45 PM EST
Neoadjuvant Pembrolizumab Administered Before Surgery Improves Outcomes of Melanoma Patients
Moffitt Cancer Center

A team of researchers from institutions across the United States, including Moffitt Cancer Center, launched a phase 2 clinical trial evaluating a new treatment option for this patient population. Their results, published in The New England Journal of Medicine, show that treating resectable stage 3 and 4 melanoma patients with the immunotherapy drug pembrolizumab both before and after surgery greatly improves outcomes when compared to pembrolizumab given only after surgery.

Released: 1-Mar-2023 12:05 PM EST
Global Efforts to Eliminate Mercury Skin Lightening Products
Biodiversity Research Institute (BRI)

Led by the UN Environment Programme (UNEP), with funding from the Global Environment Facility, and executed by the World Health Organization (WHO) and Biodiversity Research Institute (BRI), the Eliminating mercury skin lightening products project will work to reduce the risk of exposure to mercury-added skin lightening products, raising awareness of the health risks associated with their use, developing model regulations to reduce their circulation, and halting production, trade, and distribution across domestic and international markets.

   
Newswise: Low income, race, and rural residence among risk factors for low telemedicine literacy
Released: 24-Feb-2023 10:00 AM EST
Low income, race, and rural residence among risk factors for low telemedicine literacy
Wolters Kluwer Health: Lippincott

Demographic factors including low income and living in a rural area are linked to low telemedicine literacy – which may limit access to plastic surgeons and other healthcare providers at a time of expanding use of telehealth and video visits, according to a report in the March issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 22-Feb-2023 12:00 PM EST
MD Anderson Research Highlights for February 22, 2023
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments include a new understanding of how HPV drives cancer development, a combination therapy to overcome treatment resistance in mantle cell lymphoma, novel insights into memory T cell formation and potential therapeutic strategies for brain cancers, improved survival outcomes for metastatic colorectal cancer, targeting myeloperoxidase to improve immunotherapy responses in melanoma, and preclinical results of a combination therapy that could effectively treat a subset of acute myeloid leukemia.

   
Released: 21-Feb-2023 7:35 PM EST
Pill for skin disease also curbs excessive drinking
Oregon Health & Science University

Researchers from Oregon Health & Science University and institutions across the country have identified a pill used to treat a common skin disease as an “incredibly promising” treatment for alcohol use disorder.

Released: 21-Feb-2023 2:05 PM EST
A New Catalyst For Recycling Plastic, New Antioxidants Found In Meat, And Other Chemical Research News
Newswise

Below are some of the latest articles that have been added to the Chemistry news channel on Newswise.

Released: 16-Feb-2023 4:00 PM EST
Cancer patients who don’t respond to immunotherapy lack crucial immune cells
Washington University in St. Louis

Cancer immunotherapy involves using activated T cells to destroy tumors, but it doesn’t work for all patients. Researchers at Washington University School of Medicine in St. Louis have discovered that a kind of dendritic cell is crucial for determining the effectiveness of immunotherapy. The discovery could lead to new ways to extend the benefits of immunotherapy to more patients.

Newswise:Video Embedded how-to-get-the-best-results-from-fillers
VIDEO
Released: 16-Feb-2023 10:05 AM EST
How to get the best results from fillers
American Academy of Dermatology

When we’re young, our skin is soft, supple, and well hydrated, but as we age, our skin slowly loses its youthful characteristics, which can leave some people looking for a way to regain their younger-looking skin. If you’re interested in adding more fullness to your skin, then fillers may be for you.

7-Feb-2023 3:05 PM EST
New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition
Mount Sinai Health System

Notalgia paresthetica is a common and underdiagnosed condition characterized by a persistent itch in the upper back. To date, there are no FDA-approved treatments specifically targeting this disorder. But a new study, published in the NEJM, suggests that patients with the disorder could potentially get relief with oral difelikefalin.

Released: 7-Feb-2023 4:10 PM EST
Use of methotrexate is associated with an increased risk of skin cancer
University of Gothenburg

The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows.

Newswise:Video Embedded spot-the-cancer-new-advances-in-melanoma-detection
VIDEO
Released: 1-Feb-2023 11:05 PM EST
Spot the cancer: new advances in melanoma detection
University of South Australia

New biomarkers to improve skin cancer detection and avoid delays in treatment are being developed by researchers at the University of South Australia.

Released: 1-Feb-2023 12:50 PM EST
Medicines that modify the circadian clock might help heal scars more cleanly
Frontiers

Healing often leaves a scar. But the role of the scar itself in healing is often underestimated: a scar that doesn’t heal cleanly can be painful or upsetting or affect the range of movement of the affected body part.

Newswise: New Non-Invasive Method to Assess Burns Shows High Accuracy
Released: 1-Feb-2023 9:35 AM EST
New Non-Invasive Method to Assess Burns Shows High Accuracy
Stony Brook University

A team of Stony Brook University researchers believe they created a new method to significantly improve burn assessment. They are employing a physics-based neural network model that uses terahertz time-domain spectroscopy (THz-TDS) data for non-invasive burn assessment. Details of their method are published in a paper in Biomedical Optics Express.

   
Released: 31-Jan-2023 5:05 PM EST
The latest research news on surgery and transplants
Newswise

Below are some of the latest articles that have been added to the Surgery and the Transplantation channels on Newswise, a free source for journalists.



close
2.13389